Moderna hires chief commercial officer as it ramps up COVID vaccine rollout; plus MorphoSys, Silence, Verastem, Viking, Destiny and Allen Institute

Corinne Le Goff will join Moderna Inc. (NASDAQ:MRNA) as chief commercial officer on Jan. 19, in the midst of the mRNA company’s launch of its COVID-19 vaccine. Moderna COVID-19 vaccine (mRNA-1273) has emergency use authorization from FDA and on Wednesday gained condition marketing approval from the European Commission. Le Goff was SVP and president of the U.S. business organization at Amgen Inc. (NASDAQ:AMGN). 

Cancer and autoimmune diseases play MorphoSys AG (NASDAQ:MOR; Xetra:MOR) said Sung Lee will succeed Jens Holstein as CFO, effective Feb. 2. Lee, who was CFO at Sangamo Therapeutics Inc. (NASDAQ:SGMO), will lead corporate finance functions as a member of the company’s management board. ...